1. Home
  2. CRAI vs NVAX Comparison

CRAI vs NVAX Comparison

Compare CRAI & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRA International Inc.

CRAI

CRA International Inc.

HOLD

Current Price

$168.33

Market Cap

1.2B

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.05

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRAI
NVAX
Founded
1965
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
1998
1996

Fundamental Metrics

Financial Performance
Metric
CRAI
NVAX
Price
$168.33
$8.05
Analyst Decision
Buy
Hold
Analyst Count
1
9
Target Price
$245.00
$11.33
AVG Volume (30 Days)
127.1K
3.0M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
1.48%
N/A
EPS Growth
20.77
309.76
EPS
8.14
N/A
Revenue
$751,583,000.00
$1,123,479,000.00
Revenue This Year
$7.82
N/A
Revenue Next Year
$5.14
N/A
P/E Ratio
$20.99
N/A
Revenue Growth
9.33
64.69
52 Week Low
$132.17
$6.20
52 Week High
$227.29
$11.85

Technical Indicators

Market Signals
Indicator
CRAI
NVAX
Relative Strength Index (RSI) 48.79 47.45
Support Level $152.37 $7.70
Resistance Level $179.62 $10.10
Average True Range (ATR) 7.81 0.29
MACD -2.06 0.11
Stochastic Oscillator 21.81 75.00

Price Performance

Historical Comparison
CRAI
NVAX

About CRAI CRA International Inc.

CRA International Inc is a consulting firm specializing in providing economic, financial and management consulting services. The company provides advisory services on economic and financial matters related to litigation and regulatory proceedings, and advises corporations on business and performance-related matters. Its consulting services are organized into two areas: litigation, regulatory and financial consulting, and management consulting. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. It derives revenues by providing professional and consulting services. Geographically, the maximum revenue is derived from the United States, followed by United Kingdom and other regions.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: